共 362 条
[1]
Slamon DJ(1989)Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707-712
[2]
Godolphin W(1994)Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells Oncogene 9 1829-1838
[3]
Jones LA(1998)Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs Oncogene 17 2235-2249
[4]
Holt JA(1999)Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease J Clin Oncol 17 2639-2648
[5]
Wong SG(1998)Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment J Clin Oncol 16 2659-2671
[6]
Keith DE(2001)Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783-792
[7]
Levin WJ(2001)First-line Herceptin monotherapy in metastatic breast cancer Oncology 61 37-42
[8]
Stuart SG(2014)Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831 J Clin Oncol 32 3744-3752
[9]
Udove J(2015)Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer N Engl J Med 372 134-141
[10]
Ullrich A(2019)Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer J Clin Oncol 37 1868-1875